1. Home
  2. NMAD vs RNTX Comparison

NMAD vs RNTX Comparison

Compare NMAD & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Power Solutions Inc. Common Stock

NMAD

Nomad Power Solutions Inc. Common Stock

N/A

Current Price

$4.32

Market Cap

73.7M

Sector

Health Care

ML Signal

N/A

RNTX

Rein Therapeutics Inc.

N/A

Current Price

$0.79

Market Cap

65.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NMAD
RNTX
Founded
2020
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
65.3M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
NMAD
RNTX
Price
$4.32
$0.79
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
171.5K
★ 337.1K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
20.75
★ 44.16
EPS
N/A
★ N/A
Revenue
★ $200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.12
$0.69
52 Week High
$6.28
$2.18

Technical Indicators

Market Signals
Indicator
NMAD
RNTX
Relative Strength Index (RSI) 60.94 48.18
Support Level $3.14 $0.71
Resistance Level $4.55 $0.87
Average True Range (ATR) 0.27 0.06
MACD 0.10 0.00
Stochastic Oscillator 89.78 34.91

Price Performance

Historical Comparison
NMAD
RNTX

About NMAD Nomad Power Solutions Inc. Common Stock

Nomad Power Solutions Inc is a pioneering mobile, utility-grade truck-transportable battery energy storage system. The company's first-to-market products provide one megawatt of instantaneous power to an electrical grid or facility, bypassing months of construction typically required for traditional fixed installations. Its patented platforms, which are deployed on semi-trailers, serve emerging AI-driven applications, along with utilities, industrial operators, government agencies, and critical infrastructure providers through equipment sales, rentals and Energy-as-a-Service offerings. The group's products are Traveler, Voyager Eagle, Voyager Falcon, Voyager Hawk, and Compare Products. Its applications are Utilities, Peak Shaving, EV Charging, and Mining.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: